Status of the “Disappearing Stent” in Europe: It’s Complicated!

An updated version of our article on Abbott ’s Absorb BVS (Bioresorbable Vascular Scaffold) in the European markets. A letter, which just began circulating on Twitter last evening was actually sent to Abbott’s customers in Europe a week ago. The letter states: “Effective May 31, 2017, the device will only be available in clinical regist er setting at select sites/institutions that will play a pivotal role in the monitoring of this technology until Summer 2018 at which time the situation will be reviewed.”
Source: Burts Stent Blog : The Voice in the Ear - Category: Medical Equipment Source Type: blogs